-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Neuronetics, Raises Price Target to $6

Benzinga·08/11/2026 18:00:27
Listen to the news
BTIG analyst Sam Eiber maintains Neuronetics (NASDAQ:STIM) with a Buy and raises the price target from $5 to $6.